Liminatus Pharma, Inc. (LIMNW) — 8-K/A Filings
All 8-K/A filings from Liminatus Pharma, Inc.. Browse 1 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (1)
-
Liminatus Pharma Files 8-K/A Amendment
— Jun 2, 2025 Risk: low
Liminatus Pharma, Inc. filed an amendment (8-K/A) on June 2, 2025, related to events as of April 30, 2025. The filing concerns the completion of an acquisition
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX